Can B Corp (NASC) stock
NASCOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.01−0.00 (-1.32%)
Close on Oct 19, 2026Market cap $981.54KP/E –Yield –
Can B operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Can B's operating cash flow for the twelve months ending Sep 30, 2024 was $246.46K. For fiscal 2023 it was -$1.30M. The highest annual figure on record is -$142.43K in fiscal 2016.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$1.30M | – |
| FY2022 | Dec 31, 2022 | -$3.95M | – |
| FY2021 | Dec 31, 2021 | -$7.47M | – |
| FY2020 | Dec 31, 2020 | -$1.95M | – |
| FY2019 | Dec 31, 2019 | -$2.41M | – |
| FY2018 | Dec 31, 2018 | -$753.57K | – |
| FY2017 | Dec 31, 2017 | -$286.29K | – |
| FY2016 | Dec 31, 2016 | -$142.43K | – |
| FY2015 | Dec 31, 2015 | -$337.42K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024 | Sep 30, 2024 | $9.10K | – |
| Q2 FY2024 | Jun 30, 2024 | -$130.92K | – |
| Q1 FY2024 | Mar 31, 2024 | $216.85K | – |
| Q4 FY2023 | Dec 31, 2023 | $151.44K | – |
| Q3 FY2023 | Sep 30, 2023 | -$206.63K | – |
| Q2 FY2023 | Jun 30, 2023 | -$343.17K | – |
| Q1 FY2023 | Mar 31, 2023 | -$906.13K | – |
| Q4 FY2022 | Dec 31, 2022 | -$526.47K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.06M | – |
| Q2 FY2022 | Jun 30, 2022 | -$262.29K | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.09M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.40M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.88M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.70M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.49M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.07M | – |
| Q3 FY2020 | Sep 30, 2020 | -$348.87K | – |
| Q2 FY2020 | Jun 30, 2020 | -$521.80K | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.62K | – |
| Q4 FY2019 | Dec 31, 2019 | -$355.24K | – |
| Q3 FY2019 | Sep 30, 2019 | -$733.50K | – |
| Q2 FY2019 | Jun 30, 2019 | -$634.18K | – |
| Q1 FY2019 | Mar 31, 2019 | -$690.51K | – |
| Q4 FY2018 | Dec 31, 2018 | -$334.42K | – |
| Q3 FY2018 | Sep 30, 2018 | -$145.43K | – |
| Q2 FY2018 | Jun 30, 2018 | -$65.52K | – |
| Q1 FY2018 | Mar 31, 2018 | -$208.21K | – |
| Q4 FY2017 | Dec 31, 2017 | -$81.07K | – |
| Q3 FY2017 | Sep 30, 2017 | -$51.28K | – |
| Q2 FY2017 | Jun 30, 2017 | -$94.07K | – |
| Q1 FY2017 | Mar 31, 2017 | -$59.87K | – |
| Q4 FY2016 | Dec 31, 2016 | -$38.60K | – |
| Q3 FY2016 | Sep 30, 2016 | -$24.39K | – |
| Q2 FY2016 | Jun 30, 2016 | -$12.41K | – |
| Q1 FY2016 | Mar 31, 2016 | -$67.03K | – |
| Q4 FY2015 | Dec 31, 2015 | -$100.57K | – |
| Q3 FY2015 | Sep 30, 2015 | -$142.45K | – |
See a number that looks wrong?